TABLE 5.
Comparison of IRS1 rs2943656 polymorphism between healthy controls and the sarcopenia group
| Group | Genotype (%) | Allele (%) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| AA | AG | GG | χ 2 | p 1 | A | G | χ 2 | p 2 | |
| Sarcopenia | 2 (2.5) | 26 (32.5) | 52 (65.0) | 0.709 | 0.807 | 30 (18.75) | 130 (81.25) | 0.313 | 0.576 |
| S‐Male | 1 (2.5) | 14 (35.0) | 25 (62.5) | 2.175 | 0.328 | 16 (20.0) | 64 (80.0) | 0.040 | 0.841 |
| S‐Female | 1 (2.5) | 12 (30.0) | 27 (67.5) | 1.600 | 0.670 | 14 (17.5) | 66 (82.5) | 0.954 | 0.329 |
| Control | 4 (5.0) | 26 (32.5) | 50 (62.5) | — | — | 34 (21.25) | 126 (78.75) | — | — |
| C‐Male | 3 (7.5) | 9 (22.5) | 28 (70.0) | — | — | 15 (18.75) | 65 (81.25) | — | — |
| C‐Female | 1 (2.5) | 17 (42.5) | 22 (55.0) | — | — | 19 (23.75) | 61 (76.25) | — | — |